ischemic stroke - Nursing Case Study
Pathophysiology
• Primary mechanism: Cerebral artery occlusion leads to decreased blood flow, resulting in inadequate oxygen and glucose supply to brain tissue, initiating cellular ischemia and energy failure. Neuronal cells rapidly exhaust ATP, causing ion pump dysfunction and cellular depolarization.
• Secondary mechanism: Ischemic cascade activates excitotoxicity, where excessive glutamate release leads to calcium influx, exacerbating neuronal injury and triggering apoptosis and necrosis. Free radical production further damages cellular components.
• Key complication: Infarcted brain tissue causes cytotoxic edema and blood-brain barrier disruption, increasing intracranial pressure and possibly leading to herniation, severely impairing neurological function and potentially resulting in death.
Patient Profile
Demographics:
68-year-old female, retired teacher
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Atrial Fibrillation, Previous TIA (Transient Ischemic Attack), Hyperlipidemia
• Current medications: Warfarin, Metformin, Lisinopril, Atorvastatin, Metoprolol
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Sudden onset of right-sided weakness and difficulty speaking
• Key symptoms: Slurred speech, facial droop on the right side, numbness in the right arm and leg, severe headache, confusion
• Vital signs: Blood pressure 210/110 mmHg, heart rate 130 bpm (irregular), respiratory rate 24 breaths per minute, temperature 36.8°C, oxygen saturation 88% on room air
Section 1
As the healthcare team quickly mobilizes to manage the 68-year-old female patient, it becomes evident that her condition is deteriorating. Despite the initial administration of oxygen therapy to improve her saturation levels, her oxygen saturation remains precariously low at 92% on 4 liters of supplemental oxygen via nasal cannula. The patient is becoming increasingly lethargic, with a Glasgow Coma Scale score dropping from 14 to 10, indicating a significant decline in her level of consciousness. Her blood pressure remains severely elevated at 200/105 mmHg despite the administration of antihypertensive agents, raising concerns about the risk of further cerebral injury.
A repeat CT scan of the head reveals a substantial increase in the size of the ischemic area with signs of midline shift, suggestive of rising intracranial pressure. Laboratory results indicate a critical elevation in lactic acid levels at 6.5 mmol/L, reflecting ongoing anaerobic metabolism and cellular distress. Blood glucose levels are also elevated at 320 mg/dL, complicating the management of her diabetes and further increasing the risk of worsening cerebral edema. The patient's INR is 2.8, indicating a therapeutic level for anticoagulation, yet complicating the potential use of thrombolytic therapy due to the risk of hemorrhagic transformation.
The clinical team must now exercise advanced critical thinking to navigate this complex scenario. Decisions must be made regarding the initiation of measures to manage the intracranial pressure, such as osmotic diuresis with mannitol or hypertonic saline, while carefully considering the potential for exacerbating the patient's hemodynamic instability. The multidisciplinary team is also faced with the challenge of balancing anticoagulation management amidst the risk of hemorrhage and the need for possible surgical intervention to relieve pressure. This scenario demands a strategic and coordinated approach to optimize patient outcomes and prevent further neurological decline.
Section 2
As the healthcare team continues to monitor the 68-year-old female patient, a sudden change in her neurological status is observed. Her Glasgow Coma Scale score further declines to 8, indicating a progression to a comatose state. Pupillary response assessments reveal anisocoria, with the right pupil dilated and sluggishly reactive, suggesting worsening herniation. This alarming shift prompts an urgent reevaluation of her management plan, as maintaining cerebral perfusion and preventing irreversible brain damage become increasingly critical.
In response to the deteriorating condition, the team initiates osmotic diuresis with mannitol, administered intravenously in an attempt to decrease intracranial pressure. Simultaneously, hypertonic saline is considered to draw fluid out of the brain tissue and reduce cerebral edema. Despite these interventions, the patient's blood pressure remains perilously high at 210/110 mmHg, complicating efforts to ensure adequate cerebral perfusion without exacerbating the risk of hemorrhagic transformation.
New complications arise as laboratory values reveal acute kidney injury, with serum creatinine levels rising to 2.1 mg/dL, suggesting potential nephrotoxic effects of the osmotic diuretics and the patient's compromised hemodynamic state. The elevated creatinine further complicates fluid management strategies, as the team's ability to use diuretics is now limited by the risk of worsening renal function. This scenario necessitates a delicate balance between protecting the brain and preserving kidney function, requiring the healthcare team to reassess their approach and consider alternative therapies, such as careful titration of antihypertensive medications and consultation for potential surgical decompression.
Section 3
Amidst the unfolding complexity of the patient's condition, new diagnostic results have come to light, further complicating her clinical picture. A repeat CT scan of the brain reveals a significant midline shift of 8 mm, indicating severe cerebral edema and increased risk for herniation. The scan also shows a concerning area of hemorrhagic conversion at the periphery of the initial ischemic stroke site, suggesting that the elevated blood pressure may have contributed to a secondary bleed. This finding necessitates immediate collaboration with a neurosurgeon to evaluate the feasibility and timing of surgical decompression, such as a hemicraniectomy, to alleviate the pressure on the brain.
In parallel, arterial blood gas analysis reveals a pH of 7.28, PaCO2 of 56 mmHg, and PaO2 of 65 mmHg, indicating respiratory acidosis and significant hypoxemia. This respiratory compromise suggests that the patient's decreasing level of consciousness and potential for aspiration may have led to hypoventilation, exacerbating the cerebral insult. Given these findings, the healthcare team must swiftly decide whether to proceed with endotracheal intubation and mechanical ventilation to ensure adequate oxygenation and ventilation, crucial for maintaining cerebral perfusion.
As these developments unfold, the team is confronted with the challenge of integrating these new diagnostic insights into their management plan. They must carefully weigh the risks and benefits of surgical intervention against the patient's fragile state, while also addressing the acute respiratory failure. This multifaceted scenario demands advanced clinical judgment, as the team navigates the precarious balance between aggressive intervention and the preservation of the patient's remaining physiological reserves. The urgency of the situation underscores the need for a coordinated, multidisciplinary approach, involving critical care specialists, neurosurgeons, and nephrologists, to optimize the patient's chances of survival and recovery.
Section 4
As the healthcare team moves swiftly to address the critical situation, they decide to proceed with endotracheal intubation to secure the airway and initiate mechanical ventilation. Following successful intubation, the ventilator is set to assist-control mode with an FiO2 of 60% to optimize oxygenation. Subsequent arterial blood gas analysis shows an improvement, with a pH of 7.35, PaCO2 of 40 mmHg, and PaO2 of 90 mmHg, indicating partial correction of the respiratory acidosis and improved oxygenation. However, the patient remains deeply comatose, with a Glasgow Coma Scale score of 6, prompting ongoing neurological assessment and vigilance for further deterioration.
In parallel, the neurosurgical team evaluates the patient's candidacy for surgical intervention. A detailed discussion unfolds, weighing the potential benefits of a hemicraniectomy against the significant risks posed by the patient's unstable condition. The midline shift and hemorrhagic conversion suggest an urgent need to alleviate intracranial pressure, yet the presence of coagulopathy, reflected in a prolonged INR of 2.1 and aPTT of 42 seconds, complicates the surgical decision-making process. The team deliberates the possibility of administering fresh frozen plasma and vitamin K to address the coagulopathy, but the risk of exacerbating the hemorrhagic conversion remains a significant concern.
As the team navigates these complexities, they remain vigilant for new complications. Despite the stabilization of respiratory parameters, the patient's renal function begins to show signs of compromise, with a serum creatinine level rising to 2.3 mg/dL and a urine output decline to less than 0.5 mL/kg/hr. These findings suggest acute kidney injury, potentially secondary to hypotension and the use of nephrotoxic medications. The nephrology team is consulted to evaluate the need for renal support therapy. The evolving scenario requires continuous reassessment and dynamic adjustments to the management strategy, with all team members prepared to adapt to the rapidly changing clinical landscape.
Section 5
As the medical team continues to monitor the patient closely, a change in status becomes evident. Despite initial stabilization efforts, the patient's neurological condition worsens, now exhibiting anisocoria with a dilated right pupil and sluggish response to light, suggesting increased intracranial pressure and possible herniation. The patient's blood pressure begins to show signs of instability, with systolic readings fluctuating between 85 and 95 mmHg, exacerbating concerns about cerebral perfusion. Tachycardia has developed, with a heart rate escalating to 130 bpm. These changes prompt an urgent need to reassess the current treatment strategy and consider additional interventions to prevent further deterioration.
In response to these alarming signs, the medical team decides to initiate hyperosmolar therapy using 3% hypertonic saline, aiming to reduce cerebral edema and stabilize intracranial dynamics. Continuous infusion is carefully titrated, with serial serum sodium levels monitored to avoid rapid shifts that could precipitate central pontine myelinolysis. Meanwhile, the neurosurgical team revisits the possibility of surgical intervention, debating whether the risk of acute decompensation outweighs the potential complications of surgery in the presence of coagulopathy.
Simultaneously, the nephrology team assesses the progression of acute kidney injury, noting an increase in serum creatinine to 3.0 mg/dL and a persistently low urine output. Given the patient's hemodynamic instability, the decision is made to initiate continuous renal replacement therapy (CRRT) to manage fluid balance and support renal function. The multidisciplinary team's coordinated efforts underscore the complexity of the patient's condition, necessitating ongoing critical thinking and swift adjustments to the management plan as they work to stabilize the patient and mitigate the risk of multi-organ failure.